QPharma and Disphar are now Sever Pharma Solutions

Disphar International and QPharma has formed a new company that can provide customers with unique capabilities and expertise. Sever Pharma Solutions is the committed CDMO specialized in enhancing high potent pharma solutions and bringing pharmaceutical ideas to life.

The company will be able to add value through the entire development and manufacturing processes with in-depth analytics, expertise in high potent drugs and polymer-based drug delivery systems, comprehensive material options, and creative solutions. By providing a complete value chain, from development to sourcing and worldwide commercial supply, Sever Pharma Solutions can offer an optimized end-to-end solution.
As a committed long-term partner with a strong focus on creating a commercial product, the company will put all its resources at work for the customers. Sever Pharma Solutions also has a global GMP compliance, regulatory services, and market access strategies to secure that the customers’ products will benefit patients all over the world.

Kenneth Stokholm

President and CEO
Sever Pharma Solutions